HomeCompareANGN vs YUM

ANGN vs YUM: Dividend Comparison 2026

ANGN yields 200.00% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ANGN wins by $119.26M in total portfolio value
10 years
ANGN
ANGN
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full ANGN calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — ANGN vs YUM

📍 ANGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodANGNYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ANGN + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ANGN pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANGN
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, ANGN beats the other by $51,115,718.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANGN + YUM for your $10,000?

ANGN: 50%YUM: 50%
100% YUM50/50100% ANGN
Portfolio after 10yr
$59.74M
Annual income
$30,108,026.80/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

ANGN
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Price Target
$1.50
+50.0% upside vs current
Range: $1.50 — $1.50
Altman Z
-16.3
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANGN buys
0
YUM buys
0
No recent congressional trades found for ANGN or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricANGNYUM
Forward yield200.00%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$119.36M$107.0K
Annual income after 10y$60,176,096.29$39,957.33
Total dividends collected$112.49M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldHold
Analyst price target$1.50$173.15

Year-by-year: ANGN vs YUM ($10,000, DRIP)

YearANGN PortfolioANGN Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$30,700$20,000.00$10,980$280.44+$19.7KANGN
2$90,232$57,383.18$12,185$435.72+$78.0KANGN
3$254,173$157,624.56$13,722$684.14+$240.5KANGN
4$686,927$414,961.74$15,773$1,090.14+$671.2KANGN
5$1,783,118$1,048,106.39$18,650$1,773.02+$1.76MANGN
6$4,450,613$2,542,677.12$22,921$2,966.37+$4.43MANGN
7$10,693,420$5,931,263.38$29,685$5,158.69+$10.66MANGN
8$24,760,608$13,318,648.86$41,216$9,453.02+$24.72MANGN
9$55,315,649$28,821,798.66$62,672$18,571.31+$55.25MANGN
10$119,363,841$60,176,096.29$107,016$39,957.33+$119.26MANGN

ANGN vs YUM: Complete Analysis 2026

ANGNStock

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Full ANGN Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this ANGN vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANGN vs SCHDANGN vs JEPIANGN vs OANGN vs KOANGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.